Precision BioSciences Inc (DTIL)
6.50
-0.68
(-9.47%)
USD |
NASDAQ |
Nov 21, 16:00
6.73
+0.23
(+3.54%)
Pre-Market: 08:14
Precision BioSciences Revenue (Quarterly): 0.576M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.576M |
| June 30, 2024 | 49.90M |
| March 31, 2024 | 17.58M |
| December 31, 2023 | 7.038M |
| September 30, 2023 | 13.12M |
| June 30, 2023 | 19.79M |
| March 31, 2023 | 8.78M |
| December 31, 2022 | 10.60M |
| September 30, 2022 | 7.363M |
| June 30, 2022 | 3.82M |
| March 31, 2022 | 3.317M |
| December 31, 2021 | 6.339M |
| September 30, 2021 | 24.04M |
| June 30, 2021 | 68.80M |
| Date | Value |
|---|---|
| March 31, 2021 | 16.35M |
| December 31, 2020 | 8.846M |
| September 30, 2020 | 7.363M |
| June 30, 2020 | 1.078M |
| March 31, 2020 | 6.998M |
| December 31, 2019 | 6.522M |
| September 30, 2019 | 4.865M |
| June 30, 2019 | 5.389M |
| March 31, 2019 | 5.462M |
| December 31, 2018 | 4.94M |
| September 30, 2018 | 2.541M |
| June 30, 2018 | 1.874M |
| March 31, 2018 | 1.528M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.576M
Minimum
Sep 2024
68.80M
Maximum
Jun 2021
14.41M
Average
8.072M
Median
Revenue (Quarterly) Benchmarks
| Pfizer Inc | 17.70B |
| Assembly Biosciences Inc | 6.845M |
| Protagonist Therapeutics Inc | 4.675M |
| Alector Inc | 15.34M |
| Entrada Therapeutics Inc | 19.57M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.42M |
| Total Expenses (Quarterly) | 21.85M |
| EPS Diluted (Quarterly) | -2.25 |
| Enterprise Value | -29.06M |
| Profit Margin (Quarterly) | -2.85K% |
| Earnings Yield | 0.92% |
| Normalized Earnings Yield | -40.09 |